Company / Shares Outstanding
Axsome Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
48.7M
FY2025
5-year range
37.6M / 48.7M
FY2021-FY2025
Trend
+2.8%
vs FY2024
Sector context
#169 of 212
Health Care
What the data says
Axsome Therapeutics, Inc.'s shares outstanding of 48667587.00 is lower than 80% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 9 consecutive years, from 19150690.00 in FY2016 to 48667587.00 in FY2025.
Based on SEC 10-K filings.
48667587.00 in FY2025 with a 5-year CAGR of +5.5%.
Increased from 43498617.00 to 48667587.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +5.5%
- 10-Year CAGR
- -
Sector benchmark
-84.1% below sector average
Key checks
Key Insights
- Axsome Therapeutics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 2.8% year-over-year.
- Ranks #169 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 48.7M | +2.8% |
| FY2024 | 47.4M | +8.9% |
| FY2023 | 43.5M | +15.0% |
| FY2022 | 37.8M | +0.5% |
| FY2021 | 37.6M | +1.1% |
| FY2020 | 37.2M | +9.4% |
| FY2019 | 34.0M | +26.5% |
| FY2018 | 26.9M | +18.1% |
| FY2017 | 22.8M | +18.9% |
| FY2016 | 19.2M | +60.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026